GlucoTrack, Inc. 已确定其400万美元私募配售的最终定价。此次配售严格遵循纳斯达克市场规则,以市价方式执行,并成功获得单一机构投资者的全额认购。
GlucoTrack, Inc. 已确定其400万美元私募配售的最终定价。此次配售严格遵循纳斯达克市场规则,以市价方式执行,并成功获得单一机构投资者的全额认购。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.